![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmatimes.com/news/novadip_reveals_results_from_severe_bone_non-union_trial_1482819
https://www.businesswire.com/news/home/20221103005998/en/Novadip-Biosciences-Raises-Additional-EUR-40-Million-Bringing-Total-Company-Funding-to-EUR-88-Million
https://www.globenewswire.com/news-release/2021/10/28/2322313/0/en/Novadip-Biosciences-announces-EUR-19-million-Series-B-financing-backed-by-international-investors.html
http://www.pharmafile.com/news/580101/bone-regeneration-stem-cell-putty-sees-positive-results-trials
https://www.globenewswire.com/news-release/2021/06/15/2246933/0/en/Novadip-Biosciences-reports-positive-data-from-phase-I-study-of-NVD-001-for-spinal-fusion.html